| Matthew David Rynearson, PA | |
|
110 W 1325 N Ste 200, Cedar City, UT 84721-8179 | |
| (435) 586-7676 | |
| (435) 586-2290 |
| Full Name | Matthew David Rynearson |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 10 Years |
| Location | 110 W 1325 N Ste 200, Cedar City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114325511 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA09501 (Texas) | Secondary |
| 363AM0700X | Physician Assistant - Medical | 9557491-1206 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cedar City Hospital | Cedar city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cedar Ridge Family Medicine | 3971553884 | 8 |
News Archive
A minimally invasive procedure is the first effective treatment for patients who are high risk for standard open heart surgery for a leaking heart valve, a study led by a University of Virginia School of Medicine researcher has found.
Air Methods Corporation, the largest air medical transportation company in the world, recently delivered the first medically equipped Bell 429 helicopter to Mercy One, its hospital-based services customer in Des Moines, Iowa. Air Methods' Products Division is the first in the world to design, engineer, manufacture, and certify a medical interior for the Bell 429 helicopter.
Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has completed the purchase of certain diagnostics businesses of Biotest AG, including its diagnostics products in the areas of blood transfusion testing, transplantation, and infectious diseases for 45 million euros.
By adding features to commonly used chemical-engineering software packages, researchers at the University of Arkansas, the University of Akron and Chemstations Inc. have developed adaptive technology that allows blind or visually impaired students and working professionals to perform the essential functions of chemical-engineering process design.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces clinical results from ENCORE 401, a double-blind, placebo-controlled phase 2 trial, in patients with advanced non-small cell lung cancer (NSCLC). The results show that there was a survival advantage in the subset of patients with elevated E-cadherin (a molecular marker of epithelial tumors) receiving entinostat in combination with erlotinib (Tarceva®).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew David Rynearson, PA 110 W 1325 N Ste 200, Cedar City, UT 84721-8179 Ph: (435) 586-7676 | Matthew David Rynearson, PA 110 W 1325 N Ste 200, Cedar City, UT 84721-8179 Ph: (435) 586-7676 |
News Archive
A minimally invasive procedure is the first effective treatment for patients who are high risk for standard open heart surgery for a leaking heart valve, a study led by a University of Virginia School of Medicine researcher has found.
Air Methods Corporation, the largest air medical transportation company in the world, recently delivered the first medically equipped Bell 429 helicopter to Mercy One, its hospital-based services customer in Des Moines, Iowa. Air Methods' Products Division is the first in the world to design, engineer, manufacture, and certify a medical interior for the Bell 429 helicopter.
Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products, announced today that it has completed the purchase of certain diagnostics businesses of Biotest AG, including its diagnostics products in the areas of blood transfusion testing, transplantation, and infectious diseases for 45 million euros.
By adding features to commonly used chemical-engineering software packages, researchers at the University of Arkansas, the University of Akron and Chemstations Inc. have developed adaptive technology that allows blind or visually impaired students and working professionals to perform the essential functions of chemical-engineering process design.
Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, announces clinical results from ENCORE 401, a double-blind, placebo-controlled phase 2 trial, in patients with advanced non-small cell lung cancer (NSCLC). The results show that there was a survival advantage in the subset of patients with elevated E-cadherin (a molecular marker of epithelial tumors) receiving entinostat in combination with erlotinib (Tarceva®).
› Verified 1 days ago
Sarah Heaton, PA-C, MPAS Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1303 N Main St, Cedar City, UT 84721 Phone: 435-868-5500 | |
Ms. Stacie Carbine, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1303 N Main St, Cedar City, UT 84721 Phone: 435-868-5000 | |
Steve C. Newman, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 166 W 1325 N, Suite 150, Cedar City, UT 84720 Phone: 435-586-6962 Fax: 435-867-1663 | |
Jared A Green, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1870 N Main St Ste 201, Cedar City, UT 84721 Phone: 435-383-9009 Fax: 435-383-9010 | |
Makenzie Bishop, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 110 W 1325 N Ste 200, Cedar City, UT 84721 Phone: 435-586-7676 Fax: 435-586-2290 | |
Dillon Todd Jolley, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 166 W 1325 N Ste 150, Cedar City, UT 84721 Phone: 435-586-6962 |